Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907814 · ClinicalTrials.gov registry record · NA
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02907814: Clinical Trial NA study, sponsored by Rutgers, The State University of New Jersey.
NCT02907814 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02907814, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.
Primary Outcome
This measure pertains to the identification of cells in OCT scan of the participants. The inflammatory cells to be identified refer to white blood cells. The anterior segment OCT scan was used to attempt to identify these cells in the anterior chamber of the eyes of the participants.
Interventions
- DEVICE Optical Coherence Tomography (OCT)
- OTHER Eye Exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04 |
| Phase | NA |
Why NCT02907814 stopped before completion
NCT02907814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Optical Coherence Tomography (OCT) is the first listed.
NCT02907814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02907814 about?
NCT02907814 is a clinical study titled "Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography". Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intrao...
What is the current status of trial NCT02907814?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-09. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02907814?
The interventions under investigation include: Optical Coherence Tomography (OCT) (DEVICE), Eye Exam (OTHER).
Who is sponsoring clinical trial NCT02907814?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02907814's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia